Skip to content

Checked

Class IIDrug recallTerminated

Progesterone Modified Release recall

Recalled by MasterPharm LLC of South Richmond Hill, NY · FDA report 08/05/2020

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class II
Moderate
Status
Terminated
Closed 02/23/2024
Recall started
07/02/2020
Distribution
Nationwide

Reason for recall

Lack of Processing Controls (lack of assurance of conformity to specifications).

Class II: Use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Recalled product

Product
Progesterone Modified Release 200 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Lot and code info
02-05-2020:30@19, BUD 8/3/2020
Quantity
900 capsules
Recall number
D-1434-2020
Event ID
85992
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the U.S.

  • Nationwide

Recall timeline

  1. 07/02/2020Firm started the recall
  2. 07/29/2020FDA classified it as Class II
  3. 08/05/2020Published in the FDA enforcement report
  4. 02/23/2024FDA closed (terminated) the recall

All products in this recall

26 products under event 85992

More recalls from MasterPharm

Frequently asked questions

Why was Progesterone Modified Release recalled?
Lack of Processing Controls (lack of assurance of conformity to specifications).
What does Class II mean?
Class II is FDA's moderate recall category: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Where was the recalled product sold?
Nationwide in the U.S.
Is this recall still active?
The FDA lists the recall as terminated (closed 02/23/2024). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 08/05/2020 · Do not rely on openFDA to make decisions regarding medical care